Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related AXS
Janney Sees Near-Term Catalysts Lacking For AXIS Capital, Downgrades Issue
Benzinga's Top Downgrades
Related THRX
Theravance Inc Reports Prelim Tender Offer Results
Glaxosmithkline, Theravance Intend to File Relvar Ellipta for COPD in Japan

Analysts at Goldman Sachs downgraded Axis Capital Holdings (NYSE: AXS) from “neutral” to “sell.” The target price for Axis Capital has been lowered from $44 to $43. Axis Capital's shares closed at $46.34 yesterday.

Stifel Nicolaus downgraded Theravance (NASDAQ: THRX) from “buy” to “hold” and removed the price target of $37.86. Theravance's shares closed at $26.40 yesterday.

Sterne Agee downgraded SpringLeaf Holdings (NYSE: LEAF) from “buy” to “neutral.” The target price for SpringLeaf has been lowered from $30 to $28. SpringLeaf's shares closed at $26.49 yesterday.

Analysts at KeyBanc downgraded Computer Programs and Systems (NASDAQ: CPSI) from “hold” to “underweight.” The price target for Computer Programs is set to $55. Computer Programs' shares closed at $65.70 yesterday.

Latest Ratings for AXS

DateFirmActionFromTo
May 2016Janney CapitalDowngradesBuyNeutral
Apr 2016CitigroupMaintainsNeutral
Feb 2016UBSDowngradesBuyNeutral

View More Analyst Ratings for AXS
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (CPSI + AXS)

View Comments and Join the Discussion!